Port Moresby General Hospital on February 2 commissioned two key machines to support the kidney transplant program. The hospital received a human leukocyte antigen and a therapeutic drug monitoring device machine. The human leukocyte antigen machine would be used to test the donor and recipient’s compatibility, while the therapeutic drug monitoring device would monitor immunosuppressive...
Unlock this article with Premium. To access all premium content, contact us at [email protected]
Already a member? Log in here
